CDK4 and skin neoplasm: Interestingly, it was reported that in A431 skin cancer cells, EGCG did not alter the levels of p27, CDK2, and Cyclin D1 but did show inhibition of cell growth in vitro by increasing p21 and a decrease in CDK4 [48,51].